Central Lung Tumors Eligible for Stereotactic Ablative Radiotherapy (SABR) Trials: Analysis of a Cohort Treated Using MR-Guided SABR

被引:0
|
作者
Giraud, N. [1 ]
Schneiders, F. L. [1 ]
Palacios, M. A. [1 ]
de Koste, J. R. van Sornsen [1 ]
Sesan, S. [1 ]
机构
[1] Amsterdam UMC, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2041
引用
收藏
页码:E20 / E20
页数:1
相关论文
共 50 条
  • [31] Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience
    Ko, R. B.
    Jani, K.
    Sodji, Q.
    Merriott, D. J.
    Pickthorn, W.
    Bush, K.
    Maxim, P. G.
    Diehn, M.
    Loo, B. W., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S148 - S148
  • [32] TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MPLC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)
    Griffioen, Gwendolyn H.
    Lagerwaard, Frank
    Haasbeek, Cornelis J.
    Smit, Egbert
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S839 - S839
  • [33] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
    Stilwell, C.
    Steven, E.
    Sharma, R. N.
    Bissett, D.
    Shrimali, R. K.
    LUNG CANCER, 2013, 79 : S58 - S59
  • [34] Can dosimetry affect local control and survival in patients with early-stage lung cancer treated with Stereotactic Ablative Radiotherapy (SABR)? An analysis of the UK's largest cohort of lung SABR patients
    Saha, Animesh
    Beasley, Matthew
    Hatton, Nathaniel
    Dickinson, Peter
    Franks, Kevin
    Clarke, Katy
    Jain, Pooja
    Teo, Mark
    Murray, Patrick
    Lilley, John
    ACTA ONCOLOGICA, 2021, 60 (04) : 505 - +
  • [35] Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity
    Murray, Louise
    Karakaya, Ebru
    Hinsley, Samantha
    Naisbitt, Mitchell
    Lilley, John
    Snee, Michael
    Clarke, Katy
    Musunuru, Hima B.
    Ramasamy, Satiavani
    Turner, Rob
    Franks, Kevin
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1058):
  • [36] Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)
    Devpura, S.
    Siddiqui, M. S.
    Chen, D.
    Liu, D.
    Li, H.
    Kumar, S.
    Gordon, J.
    Ajlouni, M.
    Movsas, B.
    Chetty, I. J.
    XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013), 2014, 489
  • [37] Stereotactic ablative radiotherapy (SABR) for primary lung malignancy: a regional analysis of survival and recurrence outcomes amongst an elderly cohort
    Nicholas, Terese
    Periasamy, Manivannan
    Wade, Louise
    Cox, Nicola
    Comins, Charles
    Owadally, Waheeda
    Ayre, Gareth
    LUNG CANCER, 2021, 156 : S61 - S62
  • [38] The Role of stereotactic online MR-guided Radiotherapy in peripheral Lung Tumors
    Hering, Svenja
    Schaefer, Annemarie
    Marschner, Sebastian
    Trapp, Christian
    Taugner, Julian
    Kaesmann, Lukas
    Manapov, Farkhad
    Belka, Claus
    Corradini, Stefanie
    Eze, Chukwuka
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S9 - S9
  • [39] Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
    Regnery, Sebastian
    Buchele, Carolin
    Weykamp, Fabian
    Pohl, Moritz
    Hoegen, Philipp
    Eichkorn, Tanja
    Held, Thomas
    Ristau, Jonas
    Rippke, Carolin
    Koenig, Laila
    Thomas, Michael
    Winter, Hauke
    Adeberg, Sebastian
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [40] Outcomes in locally recurrent rectal cancer treated with reirradiation stereotactic ablative radiotherapy (SABR)
    Muirhead, R.
    Aitken, K.
    Holmes, J.
    Harrison, M.
    Harji, D.
    O'Cathail, S.
    Taylor, C.
    Wing, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1041 - S1042